Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
Clinical trial NCT06358651 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06358651
- Sponsor
- VistaGen Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-28
- Primary completion
- 2025-10-31
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.